ATE424196T1 - Pharmazeutische zusammensetzungen mit platin- komplexen mit sekundären xanthaten und ihre therapeutischen anwendungen - Google Patents

Pharmazeutische zusammensetzungen mit platin- komplexen mit sekundären xanthaten und ihre therapeutischen anwendungen

Info

Publication number
ATE424196T1
ATE424196T1 AT04803751T AT04803751T ATE424196T1 AT E424196 T1 ATE424196 T1 AT E424196T1 AT 04803751 T AT04803751 T AT 04803751T AT 04803751 T AT04803751 T AT 04803751T AT E424196 T1 ATE424196 T1 AT E424196T1
Authority
AT
Austria
Prior art keywords
xanthates
pharmaceutical compositions
compositions containing
platinum complexes
therapeutic applications
Prior art date
Application number
AT04803751T
Other languages
English (en)
Inventor
Eberhard Amtmann
Wolfgang Friebolin
Gerhard Schilling
Original Assignee
Deutsches Krebsforsch
Univ Ruprecht Karls Heidelberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforsch, Univ Ruprecht Karls Heidelberg filed Critical Deutsches Krebsforsch
Application granted granted Critical
Publication of ATE424196T1 publication Critical patent/ATE424196T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT04803751T 2003-12-10 2004-12-10 Pharmazeutische zusammensetzungen mit platin- komplexen mit sekundären xanthaten und ihre therapeutischen anwendungen ATE424196T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03028298A EP1541142A1 (de) 2003-12-10 2003-12-10 Pharmazeutische Zubereitungen enthaltend einen Platin Komplex mit einem zweiwertigen Xanthat und die therapeutische Verwendung der Zubereitungen

Publications (1)

Publication Number Publication Date
ATE424196T1 true ATE424196T1 (de) 2009-03-15

Family

ID=34486158

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04803751T ATE424196T1 (de) 2003-12-10 2004-12-10 Pharmazeutische zusammensetzungen mit platin- komplexen mit sekundären xanthaten und ihre therapeutischen anwendungen

Country Status (9)

Country Link
US (1) US20070248570A1 (de)
EP (2) EP1541142A1 (de)
AT (1) ATE424196T1 (de)
CA (1) CA2550280A1 (de)
DE (1) DE602004019818D1 (de)
DK (1) DK1708693T3 (de)
ES (1) ES2323589T3 (de)
PT (1) PT1708693E (de)
WO (1) WO2005058307A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8846712B2 (en) 2011-09-12 2014-09-30 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013167403A1 (en) 2012-05-09 2013-11-14 Sanofi Substituted 6-(4-hydroxy-phenyl)-1h-pyrazolo[3,4-b]pyridine derivatives as kinase inhibitors
WO2023093837A1 (zh) * 2021-11-26 2023-06-01 湖南湘源美东医药科技有限公司 含有铂类药物或者铂类药物共晶的药物组合物及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59905863D1 (de) * 1998-08-25 2003-07-10 Deutsches Krebsforsch Arzneimittel enthaltend platinkomplexverbindungen sowie deren verwendung

Also Published As

Publication number Publication date
CA2550280A1 (en) 2005-06-30
DK1708693T3 (da) 2009-06-29
US20070248570A1 (en) 2007-10-25
EP1708693A1 (de) 2006-10-11
EP1541142A1 (de) 2005-06-15
PT1708693E (pt) 2009-06-02
EP1708693B1 (de) 2009-03-04
ES2323589T3 (es) 2009-07-21
WO2005058307A1 (en) 2005-06-30
DE602004019818D1 (de) 2009-04-16

Similar Documents

Publication Publication Date Title
DE602004008105D1 (de) 42-o-alkoxyalkylrapamycinderivate und diese enthaltende zusammensetzungen
SE0301700D0 (sv) Novel compounds
DE60143857D1 (de) Zusammensetzung bestehend aus phy906 und chemotherapeutika
ATE461217T1 (de) Glp-1-verbindungen
CY1110405T1 (el) Φαρμακευτικες συνθεσεις περιλαμβανοντας δεξτρομεθορφανη και κινιδινη για την αγωγη νευρολογικων διαταραχων
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
SE0302811D0 (sv) Novel compounds
IL150767A (en) Benzopyran-containing compounds and their use in manufacture of medicaments for treatment of estrogen sensitive diseases such as endometrial cancer
AR027355A1 (es) Acidos tiazolidincarboxilicos
ATE433961T1 (de) Ansamycine mit verbesserten pharmakologischen und biologischen eigenschaften
DE69907137D1 (de) Autoklavierbare pharmazeutische zusammensetzungen mit komplexbildner
ATE243692T1 (de) Arylaminderivate und ihre verwendung als antitelomerasemittel
ATE508114T1 (de) Mit n-alkylhydroxamsäuren substituierte isoindolylverbindungen und deren pharmazeutische verwendung
ATE231872T1 (de) Thiazolopyrimidinderivate
ATE236147T1 (de) Derivate von flavonen, xanthonen und kumarinen
AR034213A1 (es) Composiciones de medicamentos sobre la base de agentes anticolinergicos e inhibidores de pde-iv
DE60216305D1 (de) Zusammensetzungen zur verabreichung von arzneimittelkombinationen
CY1113116T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
ATE319718T1 (de) Oxazolo- und furopyrimidine und deren verwendung als medikamente gegen tumore
DE60142913D1 (de) Arzneilösungen enthaltend modafinilverbindungen
SE0102716D0 (sv) Novel compounds
SE0301650D0 (sv) Novel compounds
ATE368649T1 (de) Cyanoguanidin prodrugs
ATE424196T1 (de) Pharmazeutische zusammensetzungen mit platin- komplexen mit sekundären xanthaten und ihre therapeutischen anwendungen
HRP20080597T3 (en) Cancer combination therapy comprising azd2171 and zd1839

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1708693

Country of ref document: EP

REN Ceased due to non-payment of the annual fee